ALEXZA PHARMACEUTICALS INC (ALXA)
(Delayed Data from NSDQ)
$0.94 USD
+0.02 (1.63%)
Updated Jun 20, 2016 03:53 PM ET
After-Market: $0.92 (%) 3:10 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[ALXA]
Reports for Purchase
Showing records 1 - 20 ( 68 total )
Industry: Medical - Drugs
We are dropping coverage of ALXA to reallocate our research resources.
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
Industry: Medical - Drugs
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
2Q15 Recap - It''s not the Plane, It''s the Runway
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
Loss of P-G a Material Negative; Lowering PT to $13, Downgrade to Neutral
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
3Q14 Recap - Adasuve Inflection Point Not Likely Until 2015
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
3Q14 Recap - Adasuve Inflection Point Not Likely Until 2015
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
Adasuve Will Take Time - Downgrading to Neutral as We Wait
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
1Q14 - Adasuve Launch Trajectory Still Emerging
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Industry: Medical - Drugs
Morning Summary
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
Industry: Medical - Drugs
MID-DAY SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Drugs
3Q13 Recap - Gearing up for 1Q14 Adasuve Launch
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S